Non-Opioid Pain Treatment Market was valued at US$ 4.15 Bn in 2022 and is expected to reach US$ 5.14 Bn by 2029, at a CAGR of 3.07% during a forecast period.Non-Opioid Pain Treatment Market Dynamics
The major driving factors of the global non-opioid pain treatment market are the rising geriatric population and easy & effective medications of non-opioids drugs for cancer treatment. Better healthcare facilities and the availability of sophisticated treatment options have improved life expectancy rates globally which is also boosting the growth of the market. However, preference for alternative therapies and fake products is limiting the market growth.To know about the Research Methodology:-Request Free Sample Report Arthritis is one of the most common indications of non-opioid pain management, and it is an informal way of referring to joint pain or joint disease. Neuropathic pain is a prominent form of pain related to a wide variety of common diseases & situations including cancer, and diabetes. Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium clostridium botulinum bacteria. The botulinum toxin is used to treat certain eye disorders such as crossed eyes, i.e. strabismus, uncontrolled blinking to treat muscle stiffness & spasms and to reduce the cosmetic appearance of wrinkles. Capsaicin is used in medicated creams and lotions such as topical ointments, nasal sprays, and dermal patches to relieve pain. They may reduce appetite and help lower blood pressure.
Global Non-Opioid Pain Treatment Market Regional insights
Asia-Pacific is expected to be the fastest-growing region for the global non-opioid pain treatment market. China, Japan, and India are the leading countries for non-opioid pain drugs owing to the high demand for better health management & economic conditions and growing awareness about pain medication. In addition, the growing aging population in the Asia-Pacific region is also increasing the growth of the non-opioid pain treatment market. The report covers a comprehensive study of major market drivers, restraints, opportunities, challenges, PESTEL, Porters, SWOT, and technological forecasting in the market.Global Non-Opioid Pain Treatment Market, Key Highlights:
Global market analysis and forecast, in terms of value. Comprehensive study and analysis of market drivers, restraints, and opportunities influencing the growth of the Global market Global market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided. Global market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. Global market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA), and Latin America along with country-wise segmentation. Profiles of key industry players, their strategic perspective, market positioning, and analysis of core competencies are further profiled. Competitive developments, investments, strategic expansion, and competitive landscape of the key players operating in the Global market are also profiled.Global Non-Opioid Pain Treatment Market Scope: Inquire before buying
Global Non-Opioid Pain Treatment Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 4.15 Bn. Forecast Period 2023 to 2029 CAGR: 3.07% Market Size in 2029: US $ 5.14 Bn. Segments Covered: by Products Medical Cannabis Menthol-Containing Omega 3 Fatty Acid-Containing Botulinum Toxins Capsaicin-Derived by Therapeutic Applications Orthopaedic & Musculoskeletal Pain Neuropathic Pain Cancer Pain Other Pain Global Non-Opioid Pain Treatment Market, by Region:
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Global Non-Opioid Pain Treatment Market Key Players
1.Allergan PLC 2.Aphria Inc. 3.Aurora 4.Bedrocan 5.Canopy Growth Corp. 6.Cara Therapeutics 7.Centrexion Therapeutics 8.CHT Medical 9.Cronos Group 10.GW Pharmaceuticals 11.Medical Marijuana Inc. 12.Medropharm Gmbh 13.Panag Pharma Inc. 14.Tilray 15.US Worldmeds LLC 16.Vanway Frequently Asked Questions: 1. Which region has the largest share in Global Non-Opioid Pain Treatment Market? Ans: Asia-Pacific region holds the highest share in 2022. 2. What is the growth rate of Global Non-Opioid Pain Treatment Market? Ans: The Globalmarket is growing at a CAGR of 3.07% during forecasting period 2023-2029. 3. What is scope of the Global Non-Opioid Pain Treatment market report? Ans: Global market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global market? Ans: The important key players in the Global market are – Allergan PLC, Aphria Inc., Aurora, Bedrocan, Canopy Growth Corp., Cara Therapeutics, Centrexion Therapeutics, CHT Medical, Cronos Group, GW Pharmaceuticals, Medical Marijuana Inc., Medropharm Gmbh, Panag Pharma Inc., Tilray, US Worldmeds LLC, and Vanway 5. What is the study period of this market? Ans: The Global market is studied from 2022 to 2029.
Global Non-Opioid Pain Treatment Market
1. Preface 1.1. Research Objectives 1.2. Report Scope and Market Segmentation 2. Assumptions and Research Methodology 2.1. Abbreviations 3. Executive Summary 3.1. Global Non-Opioid Pain Treatment Market Size, by Market Value (US$ Bn) and Market 4. Market Overview 4.1. Introduction 4.2. Market Dynamics 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 4.3.7. Key Trends in Global Non-Opioid Pain Treatment Market 5. Global Non-Opioid Pain Treatment Market Analysis and Forecast 5.1. Global Non-Opioid Pain Treatment Market Size& Y-o-Y Growth Analysis 5.1.1. North America 5.1.2. Europe 5.1.3. Asia Pacific 5.1.4. Middle East & Africa 5.1.5. South America 6. Global Non-Opioid Pain Treatment Market Analysis and Forecast, By Products 6.1. Introduction and Definition 6.2. Global Non-Opioid Pain Treatment Market Value Share Analysis, By Products 6.3. Global Non-Opioid Pain Treatment Market Size (US$ Bn) Forecast, By Products 6.4. Global Non-Opioid Pain Treatment Market Analysis, By Products 6.5. Global Non-Opioid Pain Treatment Market Attractiveness Analysis, By Products 6.6. Key Trends 6.6.1. Key Developments 7. Global Non-Opioid Pain Treatment Market Analysis and Forecast, By Therapeutic Applications 7.1. Introduction and Definition 7.2. Global Non-Opioid Pain Treatment Market Value Share Analysis, By Therapeutic Applications 7.3. Global Non-Opioid Pain Treatment Market Size (US$ Bn) Forecast, By Therapeutic Applications 7.4. Global Non-Opioid Pain Treatment Market Analysis, By Therapeutic Applications 7.5. Global Non-Opioid Pain Treatment Market Attractiveness Analysis, By Therapeutic Applications 7.6. Key Trends 7.6.1. Key Developments 8. Global Non-Opioid Pain Treatment Market Analysis, by Region 8.1. Global Non-Opioid Pain Treatment Market Value Share Analysis, by Region 8.2. Global Non-Opioid Pain Treatment Market Size (US$ Bn) Forecast, by Region 8.3. Global Non-Opioid Pain Treatment Market Attractiveness Analysis, by Region 8.4. Key Trends 8.4.1. Key Developments 9. North America Non-Opioid Pain Treatment Market Analysis 9.1. Key Findings 9.2. North America Non-Opioid Pain Treatment Market Overview 9.3. North America Non-Opioid Pain Treatment Market Value Share Analysis, By Products 9.4. North America Non-Opioid Pain Treatment Market Forecast, By Products 9.4.1. Medical Cannabis 9.4.2. Menthol-Containing 9.4.3. Omega 3 Fatty Acid-Containing 9.4.4. Botulinum Toxins 9.4.5. Capsaicin-Derived 9.5. North America Non-Opioid Pain Treatment Market Value Share Analysis, By Therapeutic Applications 9.6. North America Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 9.6.1. Orthopaedic & Musculoskeletal Pain 9.6.2. Neuropathic Pain 9.6.3. Cancer Pain 9.6.4. Other Pain 9.7. North America Non-Opioid Pain Treatment Market Value Share Analysis, by Country 9.8. North America Non-Opioid Pain Treatment Market Forecast, by Country 9.8.1. U.S. 9.8.2. Canada 9.9. North America Non-Opioid Pain Treatment Market Analysis, by Country 9.10. U.S. Non-Opioid Pain Treatment Market Forecast, By Products 9.10.1. Medical Cannabis 9.10.2. Menthol-Containing 9.10.3. Omega 3 Fatty Acid-Containing 9.10.4. Botulinum Toxins 9.10.5. Capsaicin-Derived 9.11. U.S. Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 9.11.1. Orthopaedic & Musculoskeletal Pain 9.11.2. Neuropathic Pain 9.11.3. Cancer Pain 9.11.4. Other Pain 9.12. Canada Non-Opioid Pain Treatment Market Forecast, By Products 9.12.1. Medical Cannabis 9.12.2. Menthol-Containing 9.12.3. Omega 3 Fatty Acid-Containing 9.12.4. Botulinum Toxins 9.12.5. Capsaicin-Derived 9.13. Canada Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 9.13.1. Orthopaedic & Musculoskeletal Pain 9.13.2. Neuropathic Pain 9.13.3. Cancer Pain 9.13.4. Other Pain 9.14. North America Non-Opioid Pain Treatment Market Attractiveness Analysis 9.14.1. By Products 9.14.2. By Therapeutic Applications 9.15. PEST Analysis 9.16. Key Trends 9.16.1. Key Developments 10. Europe Non-Opioid Pain Treatment Market Analysis 10.1. Key Findings 10.2. Europe Non-Opioid Pain Treatment Market Overview 10.3. Europe Non-Opioid Pain Treatment Market Value Share Analysis, By Products 10.4. Europe Non-Opioid Pain Treatment Market Forecast, By Products 10.4.1. Medical Cannabis 10.4.2. Menthol-Containing 10.4.3. Omega 3 Fatty Acid-Containing 10.4.4. Botulinum Toxins 10.4.5. Capsaicin-Derived 10.5. Europe Non-Opioid Pain Treatment Market Value Share Analysis, By Therapeutic Applications 10.6. Europe Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 10.6.1. Orthopaedic & Musculoskeletal Pain 10.6.2. Neuropathic Pain 10.6.3. Cancer Pain 10.6.4. Other Pain 10.7. Europe Non-Opioid Pain Treatment Market Value Share Analysis, by Country 10.8. Europe Non-Opioid Pain Treatment Market Forecast, by Country 10.8.1. Germany 10.8.2. U.K. 10.8.3. France 10.8.4. Italy 10.8.5. Spain 10.8.6. Rest of Europe 10.9. Europe Non-Opioid Pain Treatment Market Analysis, by Country/ Sub-region 10.10. Germany Non-Opioid Pain Treatment Market Forecast, By Products 10.10.1. Medical Cannabis 10.10.2. Menthol-Containing 10.10.3. Omega 3 Fatty Acid-Containing 10.10.4. Botulinum Toxins 10.10.5. Capsaicin-Derived 10.11. Germany Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 10.11.1. Orthopaedic & Musculoskeletal Pain 10.11.2. Neuropathic Pain 10.11.3. Cancer Pain 10.11.4. Other Pain 10.12. U.K. Non-Opioid Pain Treatment Market Forecast, By Products 10.12.1. Medical Cannabis 10.12.2. Menthol-Containing 10.12.3. Omega 3 Fatty Acid-Containing 10.12.4. Botulinum Toxins 10.12.5. Capsaicin-Derived 10.13. U.K. Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 10.13.1. Orthopaedic & Musculoskeletal Pain 10.13.2. Neuropathic Pain 10.13.3. Cancer Pain 10.13.4. Other Pain 10.14. France Non-Opioid Pain Treatment Market Forecast, By Products 10.14.1. Medical Cannabis 10.14.2. Menthol-Containing 10.14.3. Omega 3 Fatty Acid-Containing 10.14.4. Botulinum Toxins 10.14.5. Capsaicin-Derived 10.15. France Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 10.15.1. Orthopaedic & Musculoskeletal Pain 10.15.2. Neuropathic Pain 10.15.3. Cancer Pain 10.15.4. Other Pain 10.16. Italy Non-Opioid Pain Treatment Market Forecast, By Products 10.16.1. Medical Cannabis 10.16.2. Menthol-Containing 10.16.3. Omega 3 Fatty Acid-Containing 10.16.4. Botulinum Toxins 10.16.5. Capsaicin-Derived 10.17. Italy Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 10.17.1. Orthopaedic & Musculoskeletal Pain 10.17.2. Neuropathic Pain 10.17.3. Cancer Pain 10.17.4. Other Pain 10.18. Spain Non-Opioid Pain Treatment Market Forecast, By Products 10.18.1. Medical Cannabis 10.18.2. Menthol-Containing 10.18.3. Omega 3 Fatty Acid-Containing 10.18.4. Botulinum Toxins 10.18.5. Capsaicin-Derived 10.19. Spain Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 10.19.1. Orthopaedic & Musculoskeletal Pain 10.19.2. Neuropathic Pain 10.19.3. Cancer Pain 10.19.4. Other Pain 10.20. Rest of Europe Non-Opioid Pain Treatment Market Forecast, By Products 10.20.1. Medical Cannabis 10.20.2. Menthol-Containing 10.20.3. Omega 3 Fatty Acid-Containing 10.20.4. Botulinum Toxins 10.20.5. Capsaicin-Derived 10.21. Rest of Europe Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 10.21.1. Orthopaedic & Musculoskeletal Pain 10.21.2. Neuropathic Pain 10.21.3. Cancer Pain 10.21.4. Other Pain 10.22. Europe Non-Opioid Pain Treatment Market Attractiveness Analysis 10.22.1. By Products 10.22.2. By Therapeutic Applications 10.23. PEST Analysis 10.24. Key Trends 10.24.1. Key Developments 11. Asia Pacific Non-Opioid Pain Treatment Market Analysis 11.1. Key Findings 11.2. Asia Pacific Non-Opioid Pain Treatment Market Overview 11.3. Asia Pacific Non-Opioid Pain Treatment Market Value Share Analysis, By Products 11.4. Asia Pacific Non-Opioid Pain Treatment Market Forecast, By Products 11.4.1. Medical Cannabis 11.4.2. Menthol-Containing 11.4.3. Omega 3 Fatty Acid-Containing 11.4.4. Botulinum Toxins 11.4.5. Capsaicin-Derived 11.5. Asia Pacific Non-Opioid Pain Treatment Market Value Share Analysis, By Therapeutic Applications 11.6. Asia Pacific Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 11.6.1. Orthopaedic & Musculoskeletal Pain 11.6.2. Neuropathic Pain 11.6.3. Cancer Pain 11.6.4. Other Pain 11.7. Asia Pacific Non-Opioid Pain Treatment Market Value Share Analysis, by Country 11.8. Asia Pacific Non-Opioid Pain Treatment Market Forecast, by Country 11.8.1. China 11.8.2. India 11.8.3. Japan 11.8.4. ASEAN 11.8.5. Rest of Asia Pacific 11.9. Asia Pacific Non-Opioid Pain Treatment Market Analysis, by Country/ Sub-region 11.10. China Non-Opioid Pain Treatment Market Forecast, By Products 11.10.1. Medical Cannabis 11.10.2. Menthol-Containing 11.10.3. Omega 3 Fatty Acid-Containing 11.10.4. Botulinum Toxins 11.10.5. Capsaicin-Derived 11.11. China Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 11.11.1. Orthopaedic & Musculoskeletal Pain 11.11.2. Neuropathic Pain 11.11.3. Cancer Pain 11.11.4. Other Pain 11.12. India Non-Opioid Pain Treatment Market Forecast, By Products 11.12.1. Medical Cannabis 11.12.2. Menthol-Containing 11.12.3. Omega 3 Fatty Acid-Containing 11.12.4. Botulinum Toxins 11.12.5. Capsaicin-Derived 11.13. India Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 11.13.1. Orthopaedic & Musculoskeletal Pain 11.13.2. Neuropathic Pain 11.13.3. Cancer Pain 11.13.4. Other Pain 11.14. Japan Non-Opioid Pain Treatment Market Forecast, By Products 11.14.1. Medical Cannabis 11.14.2. Menthol-Containing 11.14.3. Omega 3 Fatty Acid-Containing 11.14.4. Botulinum Toxins 11.14.5. Capsaicin-Derived 11.15. Japan Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 11.15.1. Orthopaedic & Musculoskeletal Pain 11.15.2. Neuropathic Pain 11.15.3. Cancer Pain 11.15.4. Other Pain 11.16. ASEAN Non-Opioid Pain Treatment Market Forecast, By Products 11.16.1. Medical Cannabis 11.16.2. Menthol-Containing 11.16.3. Omega 3 Fatty Acid-Containing 11.16.4. Botulinum Toxins 11.16.5. Capsaicin-Derived 11.17. ASEAN Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 11.17.1. Orthopaedic & Musculoskeletal Pain 11.17.2. Neuropathic Pain 11.17.3. Cancer Pain 11.17.4. Other Pain 11.18. Rest of Asia Pacific Non-Opioid Pain Treatment Market Forecast, By Products 11.18.1. Medical Cannabis 11.18.2. Menthol-Containing 11.18.3. Omega 3 Fatty Acid-Containing 11.18.4. Botulinum Toxins 11.18.5. Capsaicin-Derived 11.19. Rest of Asia Pacific Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 11.19.1. Orthopaedic & Musculoskeletal Pain 11.19.2. Neuropathic Pain 11.19.3. Cancer Pain 11.19.4. Other Pain 11.20. Asia Pacific Non-Opioid Pain Treatment Market Attractiveness Analysis 11.20.1. By Products 11.20.2. By Therapeutic Applications 11.21. PEST Analysis 11.22. Key Trends 11.22.1. Key Developments 12. Middle East & Africa Non-Opioid Pain Treatment Market Analysis 12.1. Key Findings 12.2. Middle East & Africa Non-Opioid Pain Treatment Market Overview 12.3. Middle East & Africa Non-Opioid Pain Treatment Market Value Share Analysis, By Products 12.4. Middle East & Africa Non-Opioid Pain Treatment Market Forecast, By Products 12.4.1. Medical Cannabis 12.4.2. Menthol-Containing 12.4.3. Omega 3 Fatty Acid-Containing 12.4.4. Botulinum Toxins 12.4.5. Capsaicin-Derived 12.5. Middle East & Africa Non-Opioid Pain Treatment Market Value Share Analysis, By Therapeutic Applications 12.6. Middle East & Africa Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 12.6.1. Orthopaedic & Musculoskeletal Pain 12.6.2. Neuropathic Pain 12.6.3. Cancer Pain 12.6.4. Other Pain 12.7. Middle East & Africa Non-Opioid Pain Treatment Market Value Share Analysis, by Country 12.8. Middle East & Africa Non-Opioid Pain Treatment Market Forecast, by Country 12.8.1. GCC 12.8.2. South Africa 12.8.3. Rest of Middle East & Africa 12.9. Middle East & Africa Non-Opioid Pain Treatment Market Analysis, by Country/ Sub-region 12.10. GCC Non-Opioid Pain Treatment Market Forecast, By Products 12.10.1. Medical Cannabis 12.10.2. Menthol-Containing 12.10.3. Omega 3 Fatty Acid-Containing 12.10.4. Botulinum Toxins 12.10.5. Capsaicin-Derived 12.11. GCC Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 12.11.1. Orthopaedic & Musculoskeletal Pain 12.11.2. Neuropathic Pain 12.11.3. Cancer Pain 12.11.4. Other Pain 12.12. South Africa Non-Opioid Pain Treatment Market Forecast, By Products 12.12.1. Medical Cannabis 12.12.2. Menthol-Containing 12.12.3. Omega 3 Fatty Acid-Containing 12.12.4. Botulinum Toxins 12.12.5. Capsaicin-Derived 12.13. South Africa Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 12.13.1. Orthopaedic & Musculoskeletal Pain 12.13.2. Neuropathic Pain 12.13.3. Cancer Pain 12.13.4. Other Pain 12.14. Rest of Middle East & Africa Non-Opioid Pain Treatment Market Forecast, By Products 12.14.1. Medical Cannabis 12.14.2. Menthol-Containing 12.14.3. Omega 3 Fatty Acid-Containing 12.14.4. Botulinum Toxins 12.14.5. Capsaicin-Derived 12.15. Rest of Middle East & Africa Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 12.15.1. Orthopaedic & Musculoskeletal Pain 12.15.2. Neuropathic Pain 12.15.3. Cancer Pain 12.15.4. Other Pain 12.16. Middle East & Africa Non-Opioid Pain Treatment Market Attractiveness Analysis 12.16.1. By Products 12.16.2. By Therapeutic Applications 12.17. PEST Analysis 12.18. Key Trends 12.18.1. Key Developments 13. South America Non-Opioid Pain Treatment Market Analysis 13.1. Key Findings 13.2. South America Non-Opioid Pain Treatment Market Overview 13.3. South America Non-Opioid Pain Treatment Market Value Share Analysis, By Products 13.4. South America Non-Opioid Pain Treatment Market Forecast, By Products 13.4.1. Medical Cannabis 13.4.2. Menthol-Containing 13.4.3. Omega 3 Fatty Acid-Containing 13.4.4. Botulinum Toxins 13.4.5. Capsaicin-Derived 13.5. South America Non-Opioid Pain Treatment Market Value Share Analysis, By Therapeutic Applications 13.6. South America Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 13.6.1. Orthopaedic & Musculoskeletal Pain 13.6.2. Neuropathic Pain 13.6.3. Cancer Pain 13.6.4. Other Pain 13.7. South America Non-Opioid Pain Treatment Market Value Share Analysis, by Country 13.8. South America Non-Opioid Pain Treatment Market Forecast, by Country 13.8.1. Brazil 13.8.2. Mexico 13.8.3. Rest of South America 13.9. South America Non-Opioid Pain Treatment Market Analysis, by Country/ Sub-region 13.10. Brazil Non-Opioid Pain Treatment Market Forecast, By Products 13.10.1. Medical Cannabis 13.10.2. Menthol-Containing 13.10.3. Omega 3 Fatty Acid-Containing 13.10.4. Botulinum Toxins 13.10.5. Capsaicin-Derived 13.11. Brazil Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 13.11.1. Orthopaedic & Musculoskeletal Pain 13.11.2. Neuropathic Pain 13.11.3. Cancer Pain 13.11.4. Other Pain 13.12. Mexico Non-Opioid Pain Treatment Market Forecast, By Products 13.12.1. Medical Cannabis 13.12.2. Menthol-Containing 13.12.3. Omega 3 Fatty Acid-Containing 13.12.4. Botulinum Toxins 13.12.5. Capsaicin-Derived 13.13. Mexico Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 13.13.1. Orthopaedic & Musculoskeletal Pain 13.13.2. Neuropathic Pain 13.13.3. Cancer Pain 13.13.4. Other Pain 13.14. Rest of South America Non-Opioid Pain Treatment Market Forecast, By Products 13.14.1. Medical Cannabis 13.14.2. Menthol-Containing 13.14.3. Omega 3 Fatty Acid-Containing 13.14.4. Botulinum Toxins 13.14.5. Capsaicin-Derived 13.15. Rest of South America Non-Opioid Pain Treatment Market Forecast, By Therapeutic Applications 13.15.1. Orthopaedic & Musculoskeletal Pain 13.15.2. Neuropathic Pain 13.15.3. Cancer Pain 13.15.4. Other Pain 13.16. South America Non-Opioid Pain Treatment Market Attractiveness Analysis 13.16.1. By Products 13.16.2. By Therapeutic Applications 13.17. PEST Analysis 13.18. Key Trends 13.18.1. Key Developments 14. Company Landscape 14.1. Market Share Analysis, by Company 14.2. Competition Matrix 14.3. Competitive Benchmarking of Company and Services 14.4. Company Profiles: Key Players 14.4.1. Allergan PLC 14.4.1.1. Company Overview 14.4.1.2. Financial Overview 14.4.1.3. Business Strategy 14.4.1.4. Recent Developments 14.4.1.5. Development Footprint 14.4.2. Aphria Inc. 14.4.3. Aurora 14.4.4. Bedrocan 14.4.5. Canopy Growth Corp. 14.4.6. Cara Therapeutics 14.4.7. Centrexion Therapeutics 14.4.8. CHT Medical 14.4.9. Cronos Group 14.4.10. GW Pharmaceuticals 14.4.11. Medical Marijuana Inc. 14.4.12. Medropharm Gmbh 14.4.13. Panag Pharma Inc. 14.4.14. Tilray 14.4.15. US Worldmeds LLC 14.4.16. Vanway 15. Primary Key Insights